HDAC6 inhibition significantly attenuated the sepsis-associated pulmonary, hepatic, and renal injury, suggesting that inhibition of HDAC6 may form the basis of a potential therapy for sepsis and related disorders. The gene discussed is HDAC6; the disease is Sepsis.